News|Articles|May 15, 2015
- Pharmaceutical Technology-05-15-2015
- Volume 2015 eBook
- Issue 2
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
Author(s)Joseph Brower, Eugene Wexler, PhD
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Advertisement
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Download
Articles in this issue
over 10 years ago
Validating and Implementing a Rapid Sterility Testing Methodover 10 years ago
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Footover 10 years ago
Aging Facilities: Aseptic Manufacturing Faces the FutureNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
3
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
4
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
5
